Hellometer vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 37)
Hellometer logo

Hellometer

EmergingHealthcare

General

Employee mental health measurement and wellbeing platform for SMB employers with anonymized workforce assessments; $150K YC W20-backed competing with Lyra and Modern Health in employer mental health benefits.

AI VisibilityBeta
Overall Score
D37
Category Rank
#495 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
42
Perplexity
31
Gemini
35

About

Hellometer is a Santa Monica-based employee wellbeing and mental health platform founded in 2020 that provides businesses with tools to measure and improve workforce mental health — offering wellbeing assessments, resources, and manager tools that help companies understand the mental health status of their workforce and provide appropriate support. Backed by Y Combinator (W20) with $150,000 from investors including LAUNCH Fund, Intel Ignite, and Bling Capital, Hellometer operates in the growing employer mental health benefits market.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

37
Overall Score
88
#495
Category Rank
#3
74
AI Consensus
78
stable
Trend
stable
42
ChatGPT
83
31
Perplexity
87
35
Gemini
85
34
Claude
90
39
Grok
92

Key Details

Category
General
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.